Back to Search
MARIA TERESA AMBROSINI, BS,PHARM.D., BCPS
BS,PHARM.D., BCPS
Pharmacotherapy Pharmacist
NPI: 1902047178Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
RP038087T(PA)
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
039989(NY)
Research & Publications (20)
Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.
PMID 19580850·Neuroscience·2009
7-preclinical
Correlations between serum and salivary hormonal concentrations in response to resistance exercise.
PMID 18608830·J Sports Sci·2008
8-other
Hormonal responses to resistance exercise in long-term trained and untrained middle-aged men.
PMID 18714223·J Strength Cond Res·2008
8-other
Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease.
PMID 17414137·J Pediatr Gastroenterol Nutr·2007
3-trial
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
PMID 17148584·Blood·2007
3-trial
Permanent brain ischemia induces marked increments in hsp72 expression and local protein synthesis in synapses of the ischemic hemisphere.
PMID 17240064·Neurosci Lett·2007
7-preclinical
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
PMID 17785703·J Clin Oncol·2007
3-trial
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
PMID 17594696·Cancer·2007
8-other
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
PMID 16530576·Lancet·2006
4-observational
Erythrocytes as a controlled drug delivery system: clinical evidences.
PMID 17718962·J Control Release·2006
8-other
Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.
PMID 16796778·Clin Lymphoma Myeloma·2006
3-trial
Periodic treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate for fistulizing pediatric Crohn's disease: case report.
PMID 16540801·J Pediatr Gastroenterol Nutr·2006
5-case
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
PMID 16519697·Eur J Haematol·2006
3-trial
Ultrastructural investigations on protective effects of NCX 4016 (nitroaspirin) on macrovascular endothelium in diabetic Wistar rats.
PMID 16335593·J Submicrosc Cytol Pathol·2005
7-preclinical
The use of a web-based interactive geographical information system for the surveillance of bluetongue in Italy.
PMID 16642756·Rev Sci Tech·2005
7-preclinical
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant.
PMID 16191088·Eur J Haematol·2005
4-observational
Long-term parenteral nutrition in pediatric autoimmune enteropathies.
PMID 15964396·Transplant Proc·2005
8-other
Effects of light physical exercise on sleep in middle-aged rats.
PMID 15895313·Int J Sports Med·2005
4-observational
Hippocampal 72-kDa heat shock protein expression varies according to mice learning performance independently from chronic exposure to stress.
PMID 15719414·Hippocampus·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 39 W MARKET ST
BREEZY POINT, NY 11697 - Phone
- (347) 605-0358
Quick Facts
- NPI
- 1902047178
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile